Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering

S. Gnavi, L. di Blasio, C. Tonda-Turo, A. Mancardi, L. Primo, G. Ciardelli, G. Gambarotta, S. Geuna, I. Perroteau

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Hydrogels are promising materials in regenerative medicine applications, due to their hydrophilicity, biocompatibility and capacity to release drugs and growth factors in a controlled manner. In this study, biocompatible and biodegradable hydrogels based on blends of natural polymers were used in in vitro and ex vivo experiments as a tool for VEGF-controlled release to accelerate the nerve regeneration process. Among different candidates, the angiogenic factor VEGF was selected, since angiogenesis has been long recognized as an important and necessary step during tissue repair. Recent studies have pointed out that VEGF has a beneficial effect on motor neuron survival and Schwann cell vitality and proliferation. Moreover, VEGF administration can sustain and enhance the growth of regenerating peripheral nerve fibres. The hydrogel preparation process was optimized to allow functional incorporation of VEGF, while preventing its degradation and denaturation. VEGF release was quantified through ELISA assay, whereas released VEGF bioactivity was validated in human umbilical vein endothelial cells (HUVECs) and in a Schwann cell line (RT4-D6P2T) by assessing VEGFR-2 and downstream effectors Akt and Erk1/2 phosphorylation. Moreover, dorsal root ganglia explants cultured on VEGF-releasing hydrogels displayed increased neurite outgrowth, providing confirmation that released VEGF maintained its effect, as also confirmed in a tubulogenesis assay. In conclusion, a gelatin-based hydrogel system for bioactive VEGF delivery was developed and characterized for its applicability in neural tissue engineering.

Original languageEnglish
JournalJournal of Tissue Engineering and Regenerative Medicine
DOIs
Publication statusAccepted/In press - 2014

Fingerprint

Nerve Tissue
Hydrogel
Gelatin
Tissue Engineering
Peripheral Nerves
Tissue engineering
Hydrogels
Vascular Endothelial Growth Factor A
Assays
Cells
Natural polymers
Phosphorylation
Denaturation
Schwann Cells
Endothelial cells
Hydrophilicity
Bioactivity
Biocompatibility
Neurons
Repair

Keywords

  • Drug-releasing hydrogel
  • Gelatin hydrogels
  • Nerve regeneration
  • Peripheral nerve
  • Tissue engineering
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Biomaterials
  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering. / Gnavi, S.; di Blasio, L.; Tonda-Turo, C.; Mancardi, A.; Primo, L.; Ciardelli, G.; Gambarotta, G.; Geuna, S.; Perroteau, I.

In: Journal of Tissue Engineering and Regenerative Medicine, 2014.

Research output: Contribution to journalArticle

@article{d0aa5199ed9942ebb501fc8fb9068ad5,
title = "Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering",
abstract = "Hydrogels are promising materials in regenerative medicine applications, due to their hydrophilicity, biocompatibility and capacity to release drugs and growth factors in a controlled manner. In this study, biocompatible and biodegradable hydrogels based on blends of natural polymers were used in in vitro and ex vivo experiments as a tool for VEGF-controlled release to accelerate the nerve regeneration process. Among different candidates, the angiogenic factor VEGF was selected, since angiogenesis has been long recognized as an important and necessary step during tissue repair. Recent studies have pointed out that VEGF has a beneficial effect on motor neuron survival and Schwann cell vitality and proliferation. Moreover, VEGF administration can sustain and enhance the growth of regenerating peripheral nerve fibres. The hydrogel preparation process was optimized to allow functional incorporation of VEGF, while preventing its degradation and denaturation. VEGF release was quantified through ELISA assay, whereas released VEGF bioactivity was validated in human umbilical vein endothelial cells (HUVECs) and in a Schwann cell line (RT4-D6P2T) by assessing VEGFR-2 and downstream effectors Akt and Erk1/2 phosphorylation. Moreover, dorsal root ganglia explants cultured on VEGF-releasing hydrogels displayed increased neurite outgrowth, providing confirmation that released VEGF maintained its effect, as also confirmed in a tubulogenesis assay. In conclusion, a gelatin-based hydrogel system for bioactive VEGF delivery was developed and characterized for its applicability in neural tissue engineering.",
keywords = "Drug-releasing hydrogel, Gelatin hydrogels, Nerve regeneration, Peripheral nerve, Tissue engineering, Vascular endothelial growth factor",
author = "S. Gnavi and {di Blasio}, L. and C. Tonda-Turo and A. Mancardi and L. Primo and G. Ciardelli and G. Gambarotta and S. Geuna and I. Perroteau",
year = "2014",
doi = "10.1002/term.1936",
language = "English",
journal = "Journal of Tissue Engineering and Regenerative Medicine",
issn = "1932-6254",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering

AU - Gnavi, S.

AU - di Blasio, L.

AU - Tonda-Turo, C.

AU - Mancardi, A.

AU - Primo, L.

AU - Ciardelli, G.

AU - Gambarotta, G.

AU - Geuna, S.

AU - Perroteau, I.

PY - 2014

Y1 - 2014

N2 - Hydrogels are promising materials in regenerative medicine applications, due to their hydrophilicity, biocompatibility and capacity to release drugs and growth factors in a controlled manner. In this study, biocompatible and biodegradable hydrogels based on blends of natural polymers were used in in vitro and ex vivo experiments as a tool for VEGF-controlled release to accelerate the nerve regeneration process. Among different candidates, the angiogenic factor VEGF was selected, since angiogenesis has been long recognized as an important and necessary step during tissue repair. Recent studies have pointed out that VEGF has a beneficial effect on motor neuron survival and Schwann cell vitality and proliferation. Moreover, VEGF administration can sustain and enhance the growth of regenerating peripheral nerve fibres. The hydrogel preparation process was optimized to allow functional incorporation of VEGF, while preventing its degradation and denaturation. VEGF release was quantified through ELISA assay, whereas released VEGF bioactivity was validated in human umbilical vein endothelial cells (HUVECs) and in a Schwann cell line (RT4-D6P2T) by assessing VEGFR-2 and downstream effectors Akt and Erk1/2 phosphorylation. Moreover, dorsal root ganglia explants cultured on VEGF-releasing hydrogels displayed increased neurite outgrowth, providing confirmation that released VEGF maintained its effect, as also confirmed in a tubulogenesis assay. In conclusion, a gelatin-based hydrogel system for bioactive VEGF delivery was developed and characterized for its applicability in neural tissue engineering.

AB - Hydrogels are promising materials in regenerative medicine applications, due to their hydrophilicity, biocompatibility and capacity to release drugs and growth factors in a controlled manner. In this study, biocompatible and biodegradable hydrogels based on blends of natural polymers were used in in vitro and ex vivo experiments as a tool for VEGF-controlled release to accelerate the nerve regeneration process. Among different candidates, the angiogenic factor VEGF was selected, since angiogenesis has been long recognized as an important and necessary step during tissue repair. Recent studies have pointed out that VEGF has a beneficial effect on motor neuron survival and Schwann cell vitality and proliferation. Moreover, VEGF administration can sustain and enhance the growth of regenerating peripheral nerve fibres. The hydrogel preparation process was optimized to allow functional incorporation of VEGF, while preventing its degradation and denaturation. VEGF release was quantified through ELISA assay, whereas released VEGF bioactivity was validated in human umbilical vein endothelial cells (HUVECs) and in a Schwann cell line (RT4-D6P2T) by assessing VEGFR-2 and downstream effectors Akt and Erk1/2 phosphorylation. Moreover, dorsal root ganglia explants cultured on VEGF-releasing hydrogels displayed increased neurite outgrowth, providing confirmation that released VEGF maintained its effect, as also confirmed in a tubulogenesis assay. In conclusion, a gelatin-based hydrogel system for bioactive VEGF delivery was developed and characterized for its applicability in neural tissue engineering.

KW - Drug-releasing hydrogel

KW - Gelatin hydrogels

KW - Nerve regeneration

KW - Peripheral nerve

KW - Tissue engineering

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84902741182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902741182&partnerID=8YFLogxK

U2 - 10.1002/term.1936

DO - 10.1002/term.1936

M3 - Article

AN - SCOPUS:84902741182

JO - Journal of Tissue Engineering and Regenerative Medicine

JF - Journal of Tissue Engineering and Regenerative Medicine

SN - 1932-6254

ER -